Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Active specific immunotherapy for ovarian cancer.

C N Hudson, J E McHardy, O M Curling

    Lancet (London, England)
    |October 23, 1976
    PubMed
    Summary

    Active specific immunotherapy combined with chemotherapy showed improved outcomes for advanced ovarian cancer patients. This approach, using irradiated tumor cells and B.C.G., demonstrated better remission duration and survival compared to chemotherapy alone.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    <sup>75</sup>As NQR characterisation of cobaltite (CoAsS).

    Solid state nuclear magnetic resonance·2026
    Same author

    Canadian Surgery Forum 2018: St. John's, NL Sept. 13-15, 2018.

    Canadian journal of surgery. Journal canadien de chirurgie·2022
    Same author

    2021 Canadian Surgery Forum: Virtual, online Sept. 21-24, 2021.

    Canadian journal of surgery. Journal canadien de chirurgie·2022
    Same author

    ACCURACY OF CLINICAL AND RADIOGRAPHIC MEASUREMENTS OF PERIODONTAL INFRABONY DEFECTS OF DIAGNOSTIC TEST ACCURACY (DTA) STUDIES: A SYSTEMATIC REVIEW AND META-ANALYSIS.

    The journal of evidence-based dental practice·2022
    Same author

    Medical aids and breast reduction: an oxymoron.

    South African journal of surgery. Suid-Afrikaanse tydskrif vir chirurgie·2021
    Same author

    A prospective observational study of preoperative natriuretic peptide testing in adult non-cardiac surgical patients in hospitals in Western Cape Province, South Africa.

    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2021

    Area of Science:

    • Oncology
    • Immunology
    • Cancer Research

    Background:

    • Advanced or recurrent ovarian cancer presents significant treatment challenges.
    • Conventional chemotherapy often has limitations in achieving long-term disease control.
    • Combining treatments may offer synergistic benefits for ovarian cancer patients.

    Purpose of the Study:

    • To evaluate the efficacy of active specific immunotherapy combined with chemotherapy in ovarian cancer.
    • To assess the impact of this combined approach on patient survival and remission duration.
    • To compare outcomes with a control group receiving chemotherapy alone.

    Main Methods:

    • Ten patients with advanced/recurrent ovarian cancer received chemotherapy plus active specific immunotherapy.
    • Immunotherapy involved monthly inoculation with irradiated allogeneic cryopreserved tumor cells and B.C.G. after tumor stasis.

    Related Experiment Videos

  • A retrospectively matched control group received chemotherapy only.

    • Main Results:

    • Patients receiving immunotherapy showed apparently better overall remission duration.
    • Median survival was improved in the immunotherapy group.
    • Projected 24-month actuarial survival was also better compared to the control group.

    Conclusions:

    • Combining active specific immunotherapy with chemotherapy appears beneficial for advanced ovarian cancer.
    • This multimodal approach may enhance survival and remission rates.
    • Further research is warranted to confirm these findings in larger cohorts.